US226712AA57 · Corp · USD

Crispr Therapeutics Ag 144a 1.73% 2031/03

Crispr Therapeutics Ag 144aSwitzerlandPRIV PLACEMENTSenior Unsecured
MID PRICE
104.73
par = 100
YIELD TO MAT.
1.65%
semi-annual
COUPON
1.730%
semi-annual · fixed
MATURITY
2031-03-01
bullet · 4.83y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
4.60 y
1bp ↑ ≈ -0.046% P&L
Convexity
24.00
higher = more curvature
Years to maturity
4.83 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Convertible Bond
iShares
US Convertibles$10.9M▲ $94K0.18%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

26/ 100Early footprint
Interpretation. Light institutional footprint, with net accumulation
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$10.9M
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
▲ $520K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
104,732 USD
PRICE
104.73

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
CRSP 1.7308 03/01/31
FIGI
BBG020WHWH29
CUSIP
226712AA5
ISIN
US226712AA57
Type
Corp
Issued
2026-03-16
Face value
100 USD
Ticker
CRSP 1.7308 03/01/31
Sec. type
PRIV PLACEMENT
Seniority
Senior Unsecured